Long Non-coding RNA LINC01296 Promotes Progression of Oral Squamous Cell Carcinoma Through Activating the MAPK/ERK Signaling Pathway Via the MiR-485-5p/PAK4 Axis

Overview

Journal Arch Med Sci

Specialty General Medicine

Date 2022 May 20

PMID 35591837

Authors

Shuangyue Zhang

Xiaowei Wang

Dazhao Wang

Affiliations

Soon will be listed here.

Abstract

Introduction: Long intergenic non-protein-coding RNA 1296 (LINC01296), a newly identified lncRNA, can function as an oncogenic driver to promote the development of multiple carcinomas. However, the effect of LINC01296 on oral squamous cell carcinoma (OSCC) is still unclear.

Material And Methods: We determined the expression and role of LINC01296 in OSCC tissues and cell lines. The cell viability, migration and invasion were determined by MTT, wound healing assay and transwell assay, respectively. Flow cytometry was used for detecting cell cycle and apoptosis. The interaction and association between LINC01296, microRNA-485-5p (miR-485-5p) and p21 (RAC1) activated kinase 4 (PAK4) were analyzed by RNA immunoprecipitation (RIP) and luciferase reporter assays. The xenograft mouse model was established to detect the effect of LINC01296 on OSCC tumor growth.

Results: Our study showed that LINC01296 was over-expressed in OSCC tissues and cell lines. The level of LINC01296 was positively correlated with the patient's tumor node metastasis (TNM) stage and nodal invasion. Knockdown of LINC01296 effectively inhibits cell viability, migration and invasion but promotes cell apoptosis . The experiment showed that LINC01296 knockdown inhibited OSCC tumor growth. The following analysis indicated that LINC01296 acted as a ceRNA for miR-485-5p, and PAK4 was identified as a direct target of miR-485-5p. Furthermore, we found that the effects of LINC01296 on OSCC progression were through regulating the expression of PAK4/p-MEK/p-ERK via sponging miR-485-5p.

Conclusions: LINC01296 promote the cell cycle, proliferation, migration and invasion, and inhibit apoptosis of OSCC cells through activating the MAPK/ERK signaling pathway via sponging miR-485-5p to regulate PAK4 expression. These results suggested that the LINC01296/miR-485-5p/PAK4 axis was closely associated with OSCC progression. Our study provides a new insight into the molecular pathogenesis of OSCC, and may supply novel biomarkers for diagnosis and therapy of OSCC.

Citing Articles

The Prognostic Value and Clinical Significance of lncRNA SNHG5 Expression in Patients with Multiple Malignancies: A Bioinformatic and Meta-analysis.

Pashirzad M, Sahebkar A Curr Cancer Drug Targets. 2024; 24(12):1286-1297.

PMID: 38409690 DOI: 10.2174/0115680096282865240111055640.

Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways.

Rahmati A, Mafi A, Vakili O, Soleymani F, Alishahi Z, Yahyazadeh S Ann Hematol. 2023; 103(5):1455-1482.

PMID: 37526673 DOI: 10.1007/s00277-023-05383-3.

LINC01296 promotes cancer stemness traits in oral carcinomas by sponging miR-143.

Liang K, Ho D, Yang H, Hsieh P, Fang C, Tsai L J Dent Sci. 2023; 18(2):814-821.

PMID: 37021272 PMC: 10068493. DOI: 10.1016/j.jds.2023.01.008.

References

Fu X, Feng Y . QKI-5 suppresses cyclin D1 expression and proliferation of oral squamous cell carcinoma cells via MAPK signalling pathway. Int J Oral Maxillofac Surg. 2014; 44(5):562-7. DOI: 10.1016/j.ijom.2014.10.001. View

Wang R, Zuo X, Wang K, Han Q, Zuo J, Ni H . MicroRNA-485-5p attenuates cell proliferation in glioma by directly targeting paired box 3. Am J Cancer Res. 2019; 8(12):2507-2517. PMC: 6325470. View

Yang Y, Chen D, Liu H, Yang K . Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma. Cell Death Dis. 2019; 10(2):41. PMC: 6381212. DOI: 10.1038/s41419-018-1280-8. View

Wang L, Meng D, Wang Y, Hu J . Long non-coding RNA LINC01296 promotes esophageal squamous cell carcinoma cell proliferation and invasion by epigenetic suppression of KLF2. Am J Cancer Res. 2018; 8(10):2020-2029. PMC: 6220133. View

Qin Q, Yin Z, Li Y, Wang B, Zhang M . Long intergenic noncoding RNA 01296 aggravates gastric cancer cells progress through miR-122/MMP-9. Biomed Pharmacother. 2017; 97:450-457. DOI: 10.1016/j.biopha.2017.10.066. View

Chakraborty C, Sharma A, Patra B, Bhattacharya M, Sharma G, Lee S . MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia. Oncotarget. 2016; 7(27):42683-42697. PMC: 5173166. DOI: 10.18632/oncotarget.7977. View

Rupaimoole R, Slack F . MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017; 16(3):203-222. DOI: 10.1038/nrd.2016.246. View

Shi Y, Qian Z, Zhang S, Li W, Masugi Y, Li T . Cell Cycle Protein Expression in Neuroendocrine Tumors: Association of CDK4/CDK6, CCND1, and Phosphorylated Retinoblastoma Protein With Proliferative Index. Pancreas. 2017; 46(10):1347-1353. PMC: 5645256. DOI: 10.1097/MPA.0000000000000944. View

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell. 2011; 146(3):353-8. PMC: 3235919. DOI: 10.1016/j.cell.2011.07.014. View

10.

Wang X, Wang L, Gong Y, Liu Z, Qin Y, Chen J . Long noncoding RNA LINC01296 promotes cancer-cell proliferation and metastasis in urothelial carcinoma of the bladder. Onco Targets Ther. 2018; 12:75-85. PMC: 6304073. DOI: 10.2147/OTT.S192809. View

11.

Kopp F, Mendell J . Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell. 2018; 172(3):393-407. PMC: 5978744. DOI: 10.1016/j.cell.2018.01.011. View

12.

Liu B, Pan S, Xiao Y, Liu Q, Xu J, Jia L . LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway. J Exp Clin Cancer Res. 2018; 37(1):316. PMC: 6295061. DOI: 10.1186/s13046-018-0994-x. View

13.

Begum A, Imoto I, Kozaki K, Tsuda H, Suzuki E, Amagasa T . Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma. Cancer Sci. 2009; 100(10):1908-16. PMC: 11158222. DOI: 10.1111/j.1349-7006.2009.01252.x. View

14.

Seitz A, Christensen L, Christensen E, Faarkrog K, Stampe Ostenfeld M, Hedegaard J . Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer. Sci Rep. 2017; 7(1):395. PMC: 5428251. DOI: 10.1038/s41598-017-00327-0. View

15.

Feng L, Houck J, Lohavanichbutr P, Chen C . Transcriptome analysis reveals differentially expressed lncRNAs between oral squamous cell carcinoma and healthy oral mucosa. Oncotarget. 2017; 8(19):31521-31531. PMC: 5458226. DOI: 10.18632/oncotarget.16358. View

16.

Denzler R, Agarwal V, Stefano J, Bartel D, Stoffel M . Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol Cell. 2014; 54(5):766-76. PMC: 4267251. DOI: 10.1016/j.molcel.2014.03.045. View

17.

Zeng B, Li Y, Jiang F, Wei C, Chen G, Zhang W . LncRNA GAS5 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition in oral squamous cell carcinoma by regulating the miR-21/PTEN axis. Exp Cell Res. 2018; 374(2):365-373. DOI: 10.1016/j.yexcr.2018.12.014. View

18.

Eckert A, Wickenhauser C, Salins P, Kappler M, Bukur J, Seliger B . Correction to: Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma. J Transl Med. 2018; 16(1):40. PMC: 5830086. DOI: 10.1186/s12967-018-1407-9. View

19.

Labernadie A, Kato T, Brugues A, Serra-Picamal X, Derzsi S, Arwert E . A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat Cell Biol. 2017; 19(3):224-237. PMC: 5831988. DOI: 10.1038/ncb3478. View

20.

Gandellini P, Doldi V, Zaffaroni N . microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies. Semin Cancer Biol. 2017; 44:132-140. DOI: 10.1016/j.semcancer.2017.03.005. View